載入...
Pazopanib in sarcomas: expanding the PALETTE
PURPOSE OF REVIEW: After failure of standard therapy, few effective treatment options exist for adult patients with metastatic sarcomas, and median survival remains dismal at approximately 1 year. Pazopanib, a multitargeted tyrosine kinase inhibitor, has recently been approved for nonadipocytic soft...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4090026/ https://ncbi.nlm.nih.gov/pubmed/23666473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0b013e3283622d3a |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|